| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9330421 | Journal of Minimally Invasive Gynecology | 2005 | 7 Pages |
Abstract
Long-term administration of low-dose mifepristone results in myoma shrinkage and amelioration of symptoms; modest rates of low-grade endometrial hyperplasia, but no evidence of premalignant potential, also occur. Regrowth occurs slowly following cessation of the drug.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Steven H. (FACOG), Thomas MD, Kevin MD, MPH, Sean MS, David S. MD, PhD,